Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-06-26 @ 4:55 AM
Study NCT ID:
NCT07093294
Status:
RECRUITING
Last Update Posted:
2025-07-30
First Post:
2025-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study
Sponsor:
The Third Xiangya Hospital of Central South University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
fu3tianli7
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None